Following the removal of a tooth, alterations occur in the width and height of the alveolar ridge, which can pose challenges for subsequent implant treatment. In contemporary times, various augmentation materials are employed to minimize these dimensional changes and, consequently, enhance the outcomes of implant therapy. While there exist numerous augmentation materials in use today, the autogenous bone graft remains the benchmark due to its osteoinductive and osteoconductive characteristics. Nevertheless, autogenous bone grafts do come with certain challenges, including the risk of infections at the donor site, a restricted supply of available bone mass, and the rapid absorption of autogenous bone. Because of these factors, recent research has been focusing on dentin as a substitute for autogenous bone grafts. Teeth's mineral and organic composition closely resembles that of bones. Demineralized dentin contains a type I collagen framework along with growth factors that promote bone formation, making it a suitable scaffold for osteoblast growth. Dentin autologous graft demonstrates both osteoinductive and osteoconductive characteristics. Innovative instruments have been developed for grinding teeth and producing dentinal augmentatives within a brief timeframe of 15 to 20 minutes following tooth extraction. This autologous dentin graft can serve various purposes, including its application as a graft for elevating the sinus floor, guided tissue regeneration, ridge enhancement, and alveolar preservation. Furthermore, in addition to its powdered form, dentine can be employed as a block for addressing more extensive bone defects. Dentine serves as a valuable alternative to other graft materials, given its biocompatibility, absence of immune reactions in patients, and its closely matching composition to bone, making it an ideal graft material. As a result of these advantages, its utilization in various augmentation techniques has gained growing relevance.